✦ LIBER ✦

PR91 TOLERABILITY OF BEVACIZUMAB IN METASTATIC TRIPLE-NEGATIVE BREAST CANCER (TNBC) PATIENTS: A SINGLE INSTITUTION EXPERIENCE

✍ Scribed by Stamatovic, Ljiljana; Vasovic, Suzana; Milovic-Kovacevic, Marijana; Karaferic, Andjela; Lukic, Vesna; Pupovac, Simonida

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Factors affecting DFS in triple negative

✍ D. Donat; J. Pesic; J. Trifunovic; L.J. Muzikravic; S. Tesanovic; D.D. Donat 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Features of recurrence of triple negativ

✍ Ashley Alarcon-Rozas; Rosario Cueva; Jose Galarreta; Jesus Torres; Jose Ramirez; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Adjuvant chemotherapy in elderly patient

✍ Leblanc, J.; Barthelemy, P.; Wissler, M.-P.; Heitz, D.; Mathelin, C.; Waissi, W. 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 63 KB

5054 POSTER Efficacy of Biological Agent

✍ La Verde, N.M.; Bramati, A.; Sburlati, P.; Galfrascoli, E.; Moretti, A.; Bianchi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

496 RIBBON-1: efficacy of capecitabine-b

✍ H. Lindman; O. Lipatov; I. Bondarenko; L. Panasci; R. Coleman 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Clinical efficacy of Bevacizumab plus Ta

✍ Serafin Morales; J.C. Samame; T. Taberner; E. Aguirre; A. Llombart 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB